Dr. Sara Hurvitz is a medical oncologist who practices at UCLA Health’s integrative breast cancer and high-risk breast cancer clinic, Santa Monica Parkside location. She specializes in the treatment of women with breast cancer, and is involved in designing, implementing and leading national and international clinical trials to test new targeted therapies. Dr. Hurvitz maintains a robust clinical and translational research portfolio, for which she has won numerous awards over the years, including the Marni Levine Memorial Breast Cancer Research Award. She currently leads the Translation Oncology Research Laboratory at UCLA in the preclinical evaluation of novel breast cancer targets.
Dr. Hurvitz is an associate professor at the David Geffen School of Medicine at UCLA; medical director of the Jonsson Comprehensive Cancer Center Clinical Research Unit; co-director of the Santa Monica-UCLA Outpatient Oncology Practices; and director of the Breast Cancer Clinical Trials Program at UCLA. Dr. Hurvitz earned her medical degree from the University of Southern California School of Medicine. She then completed her internal medicine residency at UCLA, serving as chief resident, followed by her hematology/oncology fellowship at UCLA. She is board certified in internal medicine and medical oncology.